Two Sigma Securities, LLC Humanigen, Inc Transaction History

Two Sigma Securities, LLC

  • $5.78 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$0.13 - $0.2 $12,955 - $19,931
99,659 Added 189.91%
152,136 $22,000
Q1 2023

May 15, 2023
SELL
$0.12 - $0.23 $2,596 - $4,976
-21,639 Reduced 29.2%
52,477 $7,000
Q4 2022

Feb 14, 2023
BUY
$0.09 - $0.2 $3,157 - $7,017
35,086 Added 89.89%
74,116 $8,000
Q3 2022

Nov 14, 2022
BUY
$0.15 - $3.02 $5,854 - $117,870
39,030 New
39,030 $7,000

Others Institutions Holding HGEN

# of Institutions
4
Shares Held
558K
Call Options Held
0
Put Options Held
0
View Full List

About HUMANIGEN, INC

HGEN Quotes by TradingView
  • Ticker HGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,661,000
  • Description
  • Humanigen, Inc., a clinical-stage biopharmaceutical company, focuses on preventing and treating an immune hyper-response called ?cytokine storm'. Lenzilumab is an antibody that binds to and neutralizes granulocyte-macrophage colony-stimulating factor (GM-CSF). The company is developing lenzilumab as a treatment for cytokine storm associated with...
More about HGEN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email